/
Oil & gas field machinery & equipment company · DE · FY ends Dec · Revenue $977M · 9.10% margin
$25.78
+$0.07 (+0.27%)
EOD Jul 17, 2026
13.56% operating margin is respectable but not wide. ROIC at 7.86%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 48.0% YoY with margins expanding 6.1pp.
At 34x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
34.4x earnings. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$977M
▲ +48.0% YoY
Net Income (TTM)
$52M
▼ -40.6% YoY
Op. Margin
9.10%
▲ +6.1pp YoY
ROIC
4.86%
▲ +3.2pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$180M
▲ +104.3% YoY
Net Debt
-$100M
Net Cash Position
Cash & Equiv.
$201M
5Y CAGR: +21.8%
Continue Research
At a P/E of 34.4, Innovex International (INVX)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Innovex International scores 44/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Innovex International scores 44 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 9.1% operating margin and a 4.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh INVX's valuation and scores 44/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.